Beijing Genomics Institute adds AB SOLiD system to its next generation sequencing technologiesApril 21, 2008The Beijing Genomics Institute announced today that BGI has added Applied Biosystems SOLiD System to BGI's rapidly expanding next-generation sequencing technologies. Two AB SOLiD Systems have been installed and were thoroughly tested by the BGI researchers. The AB SOLiD System generated high-throughput high quality mate-pair data with read lengths up to 25 bp. The highest throughput reached so far is 6.8 Gb mappable data per run with the expectation of further improvement in the upcoming months. The addition of these SOLiD systems to previously established and recently purchased sequencing systems places BGI among the top sequence-producing institutes worldwide. The new next-generation sequencing platforms will be used to undertake the constantly increasing number of large-scale sequencing projects at BGI, including the Giant Panda Genome Project and the International 1000 Genomes Project. It also makes possible the expansion of the already extensive sequencing services that BGI provides to the community. Beijing Genomics Institute at Shenzhen |
|||||||||||||||||||||
| Related Sequencing Current Events and Sequencing News Articles Scientists at UA, collaborating institutions decode maize genome Scientists from the University of Arizona led by Arizona Genomics Institute director Rod A. Wing and from collaborating institutions have deciphered the complete genetic code of the maize plant for the first time. Causative gene of a rare disorder discovered by sequencing only protein-coding regions of genome For the first time, scientists have successfully used a method called exome sequencing to quickly discover a previously unknown gene responsible for a mendelian disorder. UCSD discovery allows scientists for the first time to experimentally annotate genomes Over the last 20 years, the sequencing of the human genome, along with related organisms, has represented one of the largest scientific endeavors in the history of mankind. New imagining technique could lead to better antibiotics and cancer drugs A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist. First draft of the pig: Researchers sequence swine genome A global collaborative has produced a first draft of the genome of a domesticated pig, an achievement that will lead to insights in agriculture, medicine, conservation and evolution. NIAID scientists propose new explanation for flu virus antigenic drift Influenza viruses evade infection-fighting antibodies by constantly changing the shape of their major surface protein. Genetic links to fungal infection risk identified Two genetic mutations that may put individuals at increased risk of fungal infections have been identified by scientists from UCL and Radboud University, increasing understanding about the genetic basis of these infections and potentially aiding the development of new treatments. Scientists use world's fastest supercomputer to create the largest HIV evolutionary tree Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences from HIV infected people in the hope of zeroing in on possible vaccine target areas. Testicular tumors may explain why some diseases are more common in children of older fathers A rare form of testicular tumour has provided scientists with new insights into how genetic changes (mutations) arise in our children. Standards for a new genomic era A team of geneticists at Los Alamos National Laboratory, together with a consortium of international researchers, has recently proposed a set of standards designed to elucidate the quality of publicly available genetic sequencing information. More Sequencing Current Events and Sequencing News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||